Nifty

:

25330.25

Sensex

:

82693.71

91.15 (0.36%)
313.02 (0.38%)

Login

Nifty
Sensex

:
:

25330.25
82693.71

91.15 (0.36%)
313.02 (0.38%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :

59/99

BSE: 532300 | NSE: WOCKPHARMA

Watchlist

NSE BSE

1548.20

17-Sep-2025

Open
High
Low
Previous Close

1557
1564.5
1520
1549.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

146471
227057624.6
1868.8
915

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

25,178.16
N/A
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

26,846.16
N/A
5.95

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-3.83
2.15
4.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-2.27
-
31.22

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-30.93
-56.19

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.15
2.31
2.94

EV:EBITDA (Average)

8 Years
5 Years
3 Years

58.31
48.24
53.01

Earnings Forecasts:

(Updated: 16-09-2025)

Description 2024 2025 2026 2027
Adj EPS -3.02
P/E Ratio -512.65
Revenue 2915
EBITDA 393
Net Income -47
ROA -0.6
P/B Ratio 5.78
ROE -1.22
FCFF -264
FCFF Yield -0.98
Net Debt 1342
BVPS 267.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 413.00 352.00 17.33% 355.00 355.00 0.00% 325.00 288.00 12.85% 370.00 260.00 42.31%
Expenses 282.00 272.00 3.68% 249.00 401.00 -37.91% 263.00 263.00 0.00% 321.00 270.00 18.89%
EBITDA 131.00 80.00 63.75% 106.00 -46.00 - 62.00 25.00 148.00% 49.00 -10.00 -
EBIDTM 31.72% 22.73% 29.86% -12.96% 19.08% 8.68% 13.24% -3.85%
Other Income 25.00 27.00 -7.41% 14.00 24.00 -41.67% 6.00 5.00 20.00% 11.00 6.00 83.33%
Interest 41.00 58.00 -29.31% 40.00 59.00 -32.20% 48.00 61.00 -21.31% 53.00 59.00 -10.17%
Depreciation 46.00 43.00 6.98% 40.00 45.00 -11.11% 42.00 43.00 -2.33% 43.00 44.00 -2.27%
PBT 69.00 6.00 1,050.00% 40.00 -126.00 - -22.00 -74.00 - -36.00 -107.00 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 69.00 6.00 1,050.00% 40.00 -126.00 - -22.00 -74.00 - -36.00 -107.00 -
PATM 16.71% 1.70% 11.27% -35.49% -6.77% -25.69% -9.73% -41.15%
EPS 4.25 0.37 1,048.65% 2.46 -7.75 - -1.35 -4.55 - -2.22 -6.58 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 738.00 739.00 -0.14% 743.00 700.00 6.14% 721.00 701.00 2.85% 809.00 753.00 7.44%
Expenses 666.00 648.00 2.78% 679.00 803.00 -15.44% 593.00 664.00 -10.69% 699.00 681.00 2.64%
EBITDA 72.00 91.00 -20.88% 64.00 -103.00 - 128.00 37.00 245.95% 110.00 72.00 52.78%
EBIDTM 9.76% 12.31% 8.61% -14.71% 17.75% 5.28% 13.60% 9.56%
Other Income 20.00 30.00 -33.33% 15.00 54.00 -72.22% 8.00 8.00 0.00% 9.00 24.00 -62.50%
Interest 48.00 73.00 -34.25% 48.00 73.00 -34.25% 60.00 77.00 -22.08% 73.00 76.00 -3.95%
Depreciation 56.00 54.00 3.70% 53.00 58.00 -8.62% 55.00 55.00 0.00% 55.00 55.00 0.00%
PBT -109.00 -6.00 - -22.00 -180.00 - 21.00 -87.00 - -9.00 -35.00 -
Tax -1.00 10.00 - 23.00 -3.00 - 1.00 -1.00 - 7.00 38.00 -81.58%
PAT -108.00 -16.00 - -45.00 -177.00 - 20.00 -86.00 - -16.00 -73.00 -
PATM -14.63% -2.17% -6.06% -25.29% 2.77% -12.27% -1.98% -9.69%
EPS -5.56 -0.91 - -1.54 -10.97 - 0.86 -5.76 - -1.43 -5.35 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,463.00 1,402.00 1,154.00 1,072.00 1,372.00 987.00 1,371.22 2,149.95 2,477.29 2,297.52 2,216.53 Net Sales Growth 16.57% 21.49% 7.65% -21.87% 39.01% -28.02% -36.22% -13.21% 7.82% 3.65% Cost Of Goods Sold 422.00 436.00 461.00 401.00 476.00 416.00 313.29 693.92 975.36 949.56 905.63 Gross Profit 1,041.00 966.00 693.00 671.00 896.00 571.00 1,057.93 1,456.03 1,501.93 1,347.96 1,310.90 GP Margin 71.16% 68.90% 60.05% 62.59% 65.31% 57.85% 77.15% 67.72% 60.63% 58.67% 59.14% Total Expenditure 1,115.00 1,127.00 1,190.00 1,002.00 1,150.00 1,125.00 1,401.80 2,069.48 2,154.40 2,164.07 2,090.61 Power & Fuel Cost - 75.00 68.00 54.00 62.00 55.00 61.02 66.34 55.91 83.31 86.97 % Of Sales - 5.35% 5.89% 5.04% 4.52% 5.57% 4.45% 3.09% 2.26% 3.63% 3.92% Employee Cost - 262.00 247.00 240.00 261.00 293.00 325.46 345.69 506.44 523.22 473.73 % Of Sales - 18.69% 21.40% 22.39% 19.02% 29.69% 23.74% 16.08% 20.44% 22.77% 21.37% Manufacturing Exp. - 125.00 95.00 91.00 111.00 100.00 69.69 108.02 99.61 138.04 149.79 % Of Sales - 8.92% 8.23% 8.49% 8.09% 10.13% 5.08% 5.02% 4.02% 6.01% 6.76% General & Admin Exp. - 107.00 111.00 105.00 106.00 106.00 141.75 209.01 228.47 201.10 220.67 % Of Sales - 7.63% 9.62% 9.79% 7.73% 10.74% 10.34% 9.72% 9.22% 8.75% 9.96% Selling & Distn. Exp. - 44.00 41.00 43.00 57.00 44.00 42.69 61.09 130.69 130.86 113.91 % Of Sales - 3.14% 3.55% 4.01% 4.15% 4.46% 3.11% 2.84% 5.28% 5.70% 5.14% Miscellaneous Exp. - 78.00 167.00 68.00 77.00 111.00 447.90 585.41 157.92 137.98 113.91 % Of Sales - 5.56% 14.47% 6.34% 5.61% 11.25% 32.66% 27.23% 6.37% 6.01% 6.31% EBITDA 348.00 275.00 -36.00 70.00 222.00 -138.00 -30.58 80.47 322.89 133.45 125.92 EBITDA Margin 23.79% 19.61% -3.12% 6.53% 16.18% -13.98% -2.23% 3.74% 13.03% 5.81% 5.68% Other Income 56.00 80.00 41.00 67.00 38.00 41.00 85.82 34.80 56.85 259.71 61.50 Interest 182.00 199.00 237.00 229.00 273.00 200.00 220.17 170.88 169.58 168.72 107.86 Depreciation 171.00 168.00 176.00 186.00 171.00 184.00 173.39 119.82 106.24 105.66 99.08 PBT 51.00 -12.00 -408.00 -278.00 -184.00 -481.00 -338.32 -175.43 103.92 118.78 -19.52 Tax 0.00 0.00 0.00 -47.00 -44.00 -231.00 -107.20 -93.54 35.26 -18.34 -27.86 Tax Rate 0.00% 0.00% 0.00% 9.16% 23.91% 37.08% 31.69% 53.32% 33.93% -15.44% 142.73% PAT 51.00 -12.00 -422.00 -466.00 -140.00 -392.00 -231.12 -81.89 68.66 137.12 8.34 PAT before Minority Interest 51.00 -12.00 -422.00 -466.00 -140.00 -392.00 -231.12 -81.89 68.66 137.12 8.34 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.49% -0.86% -36.57% -43.47% -10.20% -39.72% -16.86% -3.81% 2.77% 5.97% 0.38% PAT Growth 116.94% - - - - - - - -49.93% 1,544.12% EPS 3.14 -0.74 -25.97 -28.68 -8.62 -24.12 -14.22 -5.04 4.23 8.44 0.51

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 3,011.00 3,012.00 2,798.00 2,651.00 3,230.00 2,708.00 3,325.15 4,158.38 3,936.90 4,014.61 4,453.22 Net Sales Growth 4.08% 7.65% 5.55% -17.93% 19.28% -18.56% -20.04% 5.63% -1.94% -9.85% Cost Of Goods Sold 1,083.00 1,132.00 1,165.00 1,111.00 1,267.00 1,135.00 1,203.45 1,636.31 1,797.53 1,662.07 1,613.68 Gross Profit 1,928.00 1,880.00 1,633.00 1,540.00 1,963.00 1,573.00 2,121.70 2,522.07 2,139.37 2,352.54 2,839.54 GP Margin 64.03% 62.42% 58.36% 58.09% 60.77% 58.09% 63.81% 60.65% 54.34% 58.60% 63.76% Total Expenditure 2,637.00 2,619.00 2,759.00 2,550.00 2,932.00 2,771.00 3,082.03 4,050.63 3,935.07 3,988.39 3,958.98 Power & Fuel Cost - 113.00 107.00 103.00 98.00 82.00 85.41 93.30 77.80 110.10 113.99 % Of Sales - 3.75% 3.82% 3.89% 3.03% 3.03% 2.57% 2.24% 1.98% 2.74% 2.56% Employee Cost - 651.00 629.00 637.00 749.00 763.00 743.33 800.38 937.06 966.51 950.77 % Of Sales - 21.61% 22.48% 24.03% 23.19% 28.18% 22.35% 19.25% 23.80% 24.07% 21.35% Manufacturing Exp. - 170.00 142.00 126.00 169.00 145.00 120.90 153.76 135.27 179.40 228.07 % Of Sales - 5.64% 5.08% 4.75% 5.23% 5.35% 3.64% 3.70% 3.44% 4.47% 5.12% General & Admin Exp. - 196.00 190.00 192.00 224.00 251.00 186.55 380.13 476.66 504.43 405.85 % Of Sales - 6.51% 6.79% 7.24% 6.93% 9.27% 5.61% 9.14% 12.11% 12.56% 9.11% Selling & Distn. Exp. - 137.00 125.00 134.00 180.00 132.00 141.18 176.22 208.89 205.30 241.11 % Of Sales - 4.55% 4.47% 5.05% 5.57% 4.87% 4.25% 4.24% 5.31% 5.11% 5.41% Miscellaneous Exp. - 220.00 401.00 247.00 245.00 263.00 601.21 810.53 301.86 360.58 241.11 % Of Sales - 7.30% 14.33% 9.32% 7.59% 9.71% 18.08% 19.49% 7.67% 8.98% 9.11% EBITDA 374.00 393.00 39.00 101.00 298.00 -63.00 243.12 107.75 1.83 26.22 494.24 EBITDA Margin 12.42% 13.05% 1.39% 3.81% 9.23% -2.33% 7.31% 2.59% 0.05% 0.65% 11.10% Other Income 52.00 62.00 83.00 122.00 20.00 132.00 60.08 21.02 120.23 100.83 66.10 Interest 229.00 254.00 305.00 302.00 299.00 249.00 275.74 265.14 255.49 225.27 128.96 Depreciation 219.00 217.00 223.00 251.00 247.00 246.00 224.14 163.95 149.53 148.93 141.91 PBT -119.00 -16.00 -406.00 -330.00 -228.00 -426.00 -196.68 -300.32 -282.96 -247.15 289.47 Tax 30.00 41.00 52.00 -3.00 -132.00 -271.00 -153.29 -83.66 25.70 -21.11 37.88 Tax Rate -25.21% -256.25% -12.38% 0.48% 32.12% 47.71% 77.94% 27.86% -4.01% 8.54% 13.09% PAT -149.00 -47.00 -463.00 -559.00 -244.00 -299.00 -69.22 -194.53 -608.30 -195.72 250.08 PAT before Minority Interest -123.00 -57.00 -472.00 -621.00 -279.00 -297.00 -43.39 -216.66 -666.85 -226.04 251.59 Minority Interest 26.00 10.00 9.00 62.00 35.00 -2.00 -25.83 22.13 58.55 30.32 -1.51 PAT Margin -4.95% -1.56% -16.55% -21.09% -7.55% -11.04% -2.08% -4.68% -15.45% -4.88% 5.62% PAT Growth 0.00% - - - - - - - - - EPS -9.17 -2.89 -28.49 -34.40 -15.02 -18.40 -4.26 -11.97 -37.43 -12.04 15.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,763.00 1,796.00 1,753.00 2,212.00 1,606.00 994.62 1,226.63 1,294.69 1,219.32 1,167.96 Share Capital 81.00 77.00 72.00 72.00 55.00 55.37 55.34 55.32 55.27 55.25 Total Reserves 2,671.00 1,706.00 1,665.00 2,122.00 1,523.00 909.28 1,139.02 1,202.65 1,127.04 1,084.06 Non-Current Liabilities 912.00 934.00 103.00 333.00 531.00 1,212.24 1,344.91 1,257.89 1,697.40 2,109.16 Secured Loans 0.00 0.00 10.00 51.00 257.00 516.04 703.71 753.12 979.46 1,159.58 Unsecured Loans 937.00 891.00 2.00 95.00 2.00 3.46 238.22 5.27 303.16 273.26 Long Term Provisions 30.00 28.00 26.00 32.00 33.00 32.10 44.26 53.12 46.13 38.58 Current Liabilities 1,483.00 1,888.00 2,626.00 3,049.00 2,603.00 2,305.25 1,827.74 1,789.03 1,594.02 1,293.15 Trade Payables 476.00 580.00 557.00 582.00 405.00 524.36 618.75 445.79 346.35 332.50 Other Current Liabilities 510.00 552.00 727.00 1,403.00 1,037.00 855.43 611.06 814.34 518.65 379.73 Short Term Borrowings 465.00 728.00 1,315.00 1,034.00 1,066.00 880.80 561.71 437.09 661.86 550.03 Short Term Provisions 32.00 28.00 27.00 30.00 95.00 44.66 36.22 91.81 67.16 30.89 Total Liabilities 5,158.00 4,618.00 4,482.00 5,594.00 4,740.00 4,512.11 4,399.28 4,341.61 4,510.74 4,570.27 Net Block 1,276.00 1,449.00 1,625.00 1,828.00 1,684.00 2,044.35 1,614.32 1,422.73 1,464.51 1,401.80 Gross Block 3,358.00 3,374.00 3,383.00 3,412.00 3,105.00 3,315.29 2,739.84 2,428.40 2,370.85 2,205.84 Accumulated Depreciation 2,082.00 1,925.00 1,758.00 1,584.00 1,421.00 1,270.94 1,125.52 1,005.67 906.34 804.04 Non Current Assets 3,064.00 2,839.00 3,007.00 3,206.00 2,901.00 2,905.56 2,569.34 2,674.49 2,713.97 2,548.92 Capital Work in Progress 1,260.00 833.00 823.00 825.00 716.00 305.29 380.90 653.34 665.34 663.60 Non Current Investment 297.00 297.00 297.00 297.00 297.00 297.27 297.27 297.22 297.22 297.22 Long Term Loans & Adv. 229.00 243.00 245.00 238.00 203.00 202.02 236.22 277.49 277.72 186.30 Other Non Current Assets 2.00 17.00 17.00 18.00 1.00 56.63 40.63 23.71 9.18 0.00 Current Assets 1,990.00 1,668.00 1,296.00 2,244.00 1,839.00 1,606.55 1,829.94 1,667.12 1,796.77 2,021.35 Current Investments 422.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 426.00 321.00 363.00 387.00 348.00 314.93 370.04 377.07 534.72 534.81 Sundry Debtors 612.00 566.00 551.00 1,292.00 955.00 939.66 1,005.01 799.76 342.83 270.56 Cash & Bank 113.00 486.00 37.00 207.00 138.00 157.48 226.21 252.73 659.78 835.39 Other Current Assets 417.00 76.00 75.00 69.00 398.00 194.48 228.68 237.56 259.44 380.59 Short Term Loans & Adv. 376.00 219.00 270.00 289.00 192.00 137.84 228.68 231.61 199.44 380.59 Net Current Assets 507.00 -220.00 -1,330.00 -805.00 -764.00 -698.70 2.20 -121.91 202.75 728.20 Total Assets 5,054.00 4,507.00 4,303.00 5,450.00 4,740.00 4,512.11 4,399.28 4,341.61 4,510.74 4,570.27

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 4,352.00 3,359.00 3,354.00 3,849.00 3,376.00 2,671.67 2,674.80 2,852.15 3,336.71 3,775.12 Share Capital 81.00 77.00 72.00 72.00 55.00 55.37 55.34 55.32 55.27 55.25 Total Reserves 4,260.00 3,269.00 3,266.00 3,759.00 3,293.00 2,586.33 2,587.19 2,760.11 3,244.43 3,691.22 Non-Current Liabilities 887.00 617.00 -22.00 261.00 496.00 1,194.85 1,702.75 2,088.89 3,151.38 1,893.49 Secured Loans 274.00 0.00 222.00 260.00 500.00 1,237.44 1,653.25 2,167.84 2,887.11 1,647.34 Unsecured Loans 937.00 891.00 2.00 95.00 3.00 3.46 238.22 5.27 303.16 273.26 Long Term Provisions 29.00 28.00 26.00 32.00 84.00 45.60 53.48 64.89 94.23 70.74 Current Liabilities 2,043.00 2,791.00 3,435.00 3,207.00 3,121.00 3,497.18 2,863.66 2,691.71 1,978.81 1,841.85 Trade Payables 592.00 766.00 867.00 921.00 696.00 895.27 840.24 601.78 533.81 637.69 Other Current Liabilities 887.00 1,144.00 1,172.00 1,197.00 1,230.00 1,579.80 1,353.09 1,548.13 690.13 621.23 Short Term Borrowings 496.00 832.00 1,330.00 1,034.00 1,066.00 903.86 561.71 437.09 662.80 550.03 Short Term Provisions 68.00 49.00 66.00 55.00 129.00 118.25 108.62 104.71 92.07 32.90 Total Liabilities 7,586.00 7,070.00 7,075.00 7,670.00 7,376.00 7,749.49 7,571.04 7,978.48 8,848.84 7,975.79 Net Block 2,736.00 2,881.00 3,042.00 3,462.00 3,343.00 3,502.29 3,057.93 2,887.96 2,772.55 2,808.70 Gross Block 5,814.00 5,721.00 5,696.00 6,019.00 5,656.00 6,703.28 6,112.89 5,772.29 5,456.40 4,377.01 Accumulated Depreciation 3,078.00 2,840.00 2,654.00 2,557.00 2,313.00 3,200.99 3,054.96 2,884.33 2,683.85 1,568.31 Non Current Assets 5,017.00 4,886.00 4,867.00 5,081.00 4,951.00 5,319.66 4,756.39 4,598.88 4,313.57 4,023.94 Capital Work in Progress 2,033.00 1,722.00 1,539.00 1,342.00 1,379.00 1,584.53 1,445.48 1,432.57 1,243.95 1,036.05 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.45 0.45 0.45 0.45 0.45 Long Term Loans & Adv. 246.00 266.00 269.00 259.00 228.00 230.63 252.37 277.90 296.62 178.74 Other Non Current Assets 2.00 17.00 17.00 18.00 1.00 1.76 0.16 0.00 0.00 0.00 Current Assets 2,465.00 2,073.00 1,914.00 2,445.00 2,425.00 2,429.83 2,814.65 3,379.60 4,535.27 3,951.85 Current Investments 422.00 0.00 0.00 0.00 0.00 0.00 0.00 213.25 562.27 0.00 Inventories 725.00 640.00 658.00 769.00 799.00 689.83 819.36 855.71 1,107.95 1,102.16 Sundry Debtors 661.00 618.00 797.00 918.00 918.00 1,242.69 1,273.90 962.45 1,034.45 1,111.42 Cash & Bank 191.00 529.00 124.00 406.00 292.00 268.46 448.65 1,082.25 1,603.61 1,478.11 Other Current Assets 466.00 0.00 0.00 0.00 416.00 228.85 272.74 265.94 226.99 260.16 Short Term Loans & Adv. 466.00 286.00 335.00 352.00 272.00 172.21 252.56 257.63 197.75 260.16 Net Current Assets 422.00 -718.00 -1,521.00 -762.00 -696.00 -1,067.35 -49.01 687.89 2,556.46 2,110.00 Total Assets 7,482.00 6,959.00 6,781.00 7,526.00 7,376.00 7,749.49 7,571.04 7,978.48 8,848.84 7,975.79

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -14.00 188.00 71.00 -93.00 -563.00 221.51 58.33 119.38 -235.02 -363.18 PBT -12.00 -422.00 -513.00 -184.00 861.00 -338.32 -175.43 103.92 118.78 -19.52 Adjustment 321.00 494.00 433.00 410.00 -995.00 355.96 273.57 251.33 35.72 165.63 Changes in Working Capital -350.00 116.00 156.00 -240.00 -318.00 204.37 -15.40 -225.82 -364.51 -505.34 Cash after chg. in Working capital -41.00 188.00 76.00 -14.00 -452.00 222.01 82.74 129.43 -210.01 -359.23 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 27.00 0.00 -5.00 -79.00 -111.00 -0.50 -24.41 -10.05 -25.01 -3.95 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -900.00 -75.00 -3.00 -244.00 1,014.00 -16.15 120.33 450.74 368.91 -1,014.95 Net Fixed Assets -411.00 -1.00 31.00 -416.00 -200.42 -499.84 -39.00 -45.55 -166.75 -368.17 Net Investments -422.00 0.00 0.00 0.00 0.27 0.00 -0.05 0.00 0.00 0.00 Others -67.00 -74.00 -34.00 172.00 1,214.15 483.69 159.38 496.29 535.66 -646.78 Cash from Financing Activity 486.00 346.00 -236.00 430.00 -480.00 -273.97 -69.42 -523.84 -133.06 763.89 Net Cash Inflow / Outflow -428.00 459.00 -168.00 93.00 -29.00 -68.61 109.24 46.28 0.83 -614.24 Opening Cash & Equivalents 463.00 4.00 172.00 79.00 108.00 177.07 67.83 21.56 20.81 636.48 Closing Cash & Equivalent 35.00 463.00 4.00 172.00 79.00 108.46 177.07 67.83 21.56 22.47

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -22.00 219.00 153.00 413.00 -287.00 648.96 183.32 68.44 -269.47 71.61 PBT -16.00 -420.00 -624.00 -411.00 916.00 -196.68 -300.32 -641.15 -247.15 357.01 Adjustment 455.00 677.00 635.00 554.00 -943.00 483.23 444.52 448.78 303.04 201.29 Changes in Working Capital -492.00 -8.00 153.00 367.00 -143.00 379.58 80.29 278.33 -297.39 -402.76 Cash after chg. in Working capital -53.00 249.00 164.00 510.00 -170.00 666.13 224.49 85.96 -241.50 155.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 31.00 -30.00 -11.00 -97.00 -117.00 -17.17 -41.17 -17.52 -27.97 -83.93 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -783.00 -137.00 -125.00 -201.00 1,470.00 -155.53 94.57 630.24 -686.64 -818.19 Net Fixed Assets -411.00 -1.00 31.00 -416.00 -200.42 -499.84 -39.00 -45.55 -166.75 -368.17 Net Investments -422.00 0.00 0.00 0.00 0.27 0.00 -0.05 0.00 0.00 0.00 Others 50.00 -136.00 -156.00 215.00 1,670.15 344.31 133.62 675.79 -519.89 -450.02 Cash from Financing Activity 409.00 334.00 -315.00 -71.00 -1,171.00 -679.58 -776.45 -769.47 1,254.49 254.26 Net Cash Inflow / Outflow -396.00 416.00 -287.00 141.00 12.00 -186.15 -498.56 -70.79 298.38 -492.32 Opening Cash & Equivalents 505.00 90.00 370.00 232.00 219.00 397.34 897.24 963.64 662.98 1,158.69 Closing Cash & Equivalent 112.00 505.00 90.00 370.00 232.00 219.34 397.34 897.24 963.64 664.64

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 169.88 115.78 120.63 152.36 132.20 87.11 107.91 113.70 106.96 103.11 ROA -0.25% -9.27% -9.25% -2.71% -8.47% -5.19% -1.87% 1.55% 3.02% 0.18% ROE -0.53% -23.98% -23.71% -7.42% -30.83% -21.41% -6.68% 5.63% 11.81% 0.77% ROCE 4.75% -5.32% -7.92% 2.54% -13.89% -3.95% -0.15% 8.54% 8.86% 3.29% Fixed Asset Turnover 0.42 0.34 0.32 0.42 0.31 0.45 0.83 1.03 1.00 1.13 Receivable days 153.12 176.34 313.17 298.24 350.33 258.82 153.20 84.17 48.72 39.54 Inventory Days 97.10 107.98 127.44 97.55 122.58 91.16 63.42 67.17 84.96 87.21 Payable days 442.02 450.11 518.37 378.42 407.71 211.57 135.84 81.85 63.18 67.46 Cash Conversion Cycle -191.80 -165.79 -77.76 17.37 65.20 138.42 80.78 69.50 70.51 59.29 Total Debt/Equity 0.55 1.00 0.93 0.72 1.02 1.94 1.58 1.41 1.79 1.74 Interest Cover 0.94 -0.78 -1.24 0.33 -2.12 -0.54 -0.03 1.61 1.70 0.82

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 267.96 217.27 231.81 266.04 280.48 238.55 238.75 254.47 298.51 339.05 ROA -0.78% -6.67% -8.42% -3.71% -3.93% -0.57% -2.79% -7.93% -2.69% 3.25% ROE -1.48% -14.12% -17.32% -7.77% -9.92% -1.64% -7.94% -21.81% -6.42% 7.07% ROCE 4.07% -2.15% -5.88% -1.96% -5.50% 1.32% -0.56% -5.47% -0.31% 6.87% Fixed Asset Turnover 0.67 0.63 0.73 0.88 0.75 0.52 0.70 0.70 0.82 1.00 Receivable days 60.36 71.63 73.25 65.29 85.04 138.12 98.15 92.57 97.55 75.93 Inventory Days 64.42 65.71 60.95 55.76 58.60 82.83 73.51 91.03 100.47 87.00 Payable days 218.94 255.81 293.71 232.91 255.87 129.66 86.65 67.29 64.08 64.54 Cash Conversion Cycle -94.15 -118.47 -159.51 -111.86 -112.23 91.29 85.01 116.31 133.94 98.39 Total Debt/Equity 0.43 0.63 0.57 0.49 0.70 1.22 1.28 1.33 1.26 0.71 Interest Cover 0.94 -0.38 -1.07 -0.37 -1.28 0.29 -0.13 -1.51 -0.10 3.24

Top Investors:

tata mutual fund - tata small cap fund

rekha jhunjhunwala

3p india equity fund 1

hsbc small cap fund

hdfc large and mid cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Wockhardt - Quarterly Results
8th Aug 2025, 14:10 PM

Read More
Wockhardt initiates strategic realignment of US operations to focus on innovative portfolio
11th Jul 2025, 17:42 PM

The company has taken decision to exit the US generic pharmaceutical segment, paving the way for deeper focus and investment in its advanced product portfolio
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback